[HTML][HTML] Preclinical and clinical advances of GalNAc-decorated nucleic acid therapeutics
Y Huang - Molecular Therapy-Nucleic Acids, 2017 - cell.com
A main challenge in realizing the full potential of nucleic acid therapeutics is efficient
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
[HTML][HTML] Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Y Huang - Molecular Therapy. Nucleic Acids, 2017 - ncbi.nlm.nih.gov
A main challenge in realizing the full potential of nucleic acid therapeutics is efficient
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
[HTML][HTML] Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Y Huang - Molecular Therapy-Nucleic Acids, 2017 - Elsevier
A main challenge in realizing the full potential of nucleic acid therapeutics is efficient
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Y Huang - Molecular therapy. Nucleic acids, 2017 - pubmed.ncbi.nlm.nih.gov
A main challenge in realizing the full potential of nucleic acid therapeutics is efficient
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Y Huang - Molecular Therapy. Nucleic Acids, 2017 - search.proquest.com
A main challenge in realizing the full potential of nucleic acid therapeutics is efficient
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
[引用][C] Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Y Huang - Molecular Therapy-Nucleic Acids, 2017 - cir.nii.ac.jp
[PDF][PDF] Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Y Huang - Molecular Therapy, 2017 - researchgate.net
A main challenge in realizing the full potential of nucleic acid therapeutics is efficient
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
[HTML][HTML] Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Y Huang - Molecular Therapy-Nucleic Acids, 2017 - cell.com
A main challenge in realizing the full potential of nucleic acid therapeutics is efficient
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
[PDF][PDF] Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Y Huang - 2016 - cyberleninka.org
A main challenge in realizing the full potential of nucleic acid therapeutics is efficient
delivery of them into targeted tissue and cells. N-Acetylgalactosamine (GalNAc) is a well …
delivery of them into targeted tissue and cells. N-Acetylgalactosamine (GalNAc) is a well …
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics.
Y Huang - Molecular therapy. Nucleic Acids, 2016 - europepmc.org
A main challenge in realizing the full potential of nucleic acid therapeutics is efficient
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …
delivery of them into targeted tissues and cells. N-acetylgalactosamine (GalNAc) is a well …